Cargando…

1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients

BACKGROUND: Recipients of solid-organ transplants (SOT) are at increased risk of vaccine-preventable illnesses. Because of the immunosuppression administered following SOT, live vaccines are generally contraindicated post-SOT, and response to inactivated vaccines may be suboptimal. National and inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedman, Daniel, Belga, Sara, Burton, Catherine, Preiksaitis, Jutta, Kabbani, Dima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809169/
http://dx.doi.org/10.1093/ofid/ofz360.1617
_version_ 1783461919109152768
author Friedman, Daniel
Belga, Sara
Burton, Catherine
Preiksaitis, Jutta
Kabbani, Dima
author_facet Friedman, Daniel
Belga, Sara
Burton, Catherine
Preiksaitis, Jutta
Kabbani, Dima
author_sort Friedman, Daniel
collection PubMed
description BACKGROUND: Recipients of solid-organ transplants (SOT) are at increased risk of vaccine-preventable illnesses. Because of the immunosuppression administered following SOT, live vaccines are generally contraindicated post-SOT, and response to inactivated vaccines may be suboptimal. National and international guidelines recommend optimizing immunizations prior to SOT. We analyzed rates of vaccination for SOT candidates in a cohort of adult kidney and liver transplant recipients. METHODS: A retrospective chart review of adult kidney, kidney/pancreas (KP) and liver transplant recipients was conducted between 2014 and 2016. We calculated the rates of vaccinations of the following vaccines: pneumococcus, meningococcus, Hepatitis A and B, Haemophilus influenzae type B, measles, mumps, rubella, polio, tetanus, diphtheria and pertussis. RESULTS: 300 patients were included (147 kidney, 14 KP, 139 liver). Liver recipients were older (mean age 53 vs. 50; P = 0.028) and less likely to have had a previous transplant (5.8% vs. 21.1%; P < 0.001) or a living donor (15.8% vs. 32.3%, P = 0.01). Liver recipients were more likely to have been vaccinated against hepatitis A (106 [53.9%] vs. 28 [17.4%]; P < 0.001). Kidney and KP recipients were more likely to have received at least 1 dose of hepatitis B vaccine (138 [85.7%] vs. 91 [65.5%]; P < 0.001) or at least 1 dose of any of the pneumococcal vaccines (PSV23 94 [67.6%] vs. 92 [57.1%]; P = 0.062; PCV13 130 [80.7%] vs. 93 [66.9%]; P = 0.006; pneumococcal vaccine not clarified 47 [29.2%] vs. 14 [10.1%]; P < 0.001). No difference was observed with regards to other vaccines (Table 1). Being a kidney transplant recipient increased the odds of getting at least 1 dose of hepatitis B, tetanus/diphtheria/acellular pertussis (Tdap), measles, and pneumococcal vaccine (OR = 1.75, 95% CI [1.063–2.864]; P = 0.028) CONCLUSION: In our cohort, kidney transplant recipients were more likely to have received pre-transplant vaccination. Despite the availability of local and international guidelines, vaccination in SOT candidates remains suboptimal and further study of barriers to implementation of these guidelines is warranted to inform future quality improvement initiatives. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809169
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68091692019-10-28 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients Friedman, Daniel Belga, Sara Burton, Catherine Preiksaitis, Jutta Kabbani, Dima Open Forum Infect Dis Abstracts BACKGROUND: Recipients of solid-organ transplants (SOT) are at increased risk of vaccine-preventable illnesses. Because of the immunosuppression administered following SOT, live vaccines are generally contraindicated post-SOT, and response to inactivated vaccines may be suboptimal. National and international guidelines recommend optimizing immunizations prior to SOT. We analyzed rates of vaccination for SOT candidates in a cohort of adult kidney and liver transplant recipients. METHODS: A retrospective chart review of adult kidney, kidney/pancreas (KP) and liver transplant recipients was conducted between 2014 and 2016. We calculated the rates of vaccinations of the following vaccines: pneumococcus, meningococcus, Hepatitis A and B, Haemophilus influenzae type B, measles, mumps, rubella, polio, tetanus, diphtheria and pertussis. RESULTS: 300 patients were included (147 kidney, 14 KP, 139 liver). Liver recipients were older (mean age 53 vs. 50; P = 0.028) and less likely to have had a previous transplant (5.8% vs. 21.1%; P < 0.001) or a living donor (15.8% vs. 32.3%, P = 0.01). Liver recipients were more likely to have been vaccinated against hepatitis A (106 [53.9%] vs. 28 [17.4%]; P < 0.001). Kidney and KP recipients were more likely to have received at least 1 dose of hepatitis B vaccine (138 [85.7%] vs. 91 [65.5%]; P < 0.001) or at least 1 dose of any of the pneumococcal vaccines (PSV23 94 [67.6%] vs. 92 [57.1%]; P = 0.062; PCV13 130 [80.7%] vs. 93 [66.9%]; P = 0.006; pneumococcal vaccine not clarified 47 [29.2%] vs. 14 [10.1%]; P < 0.001). No difference was observed with regards to other vaccines (Table 1). Being a kidney transplant recipient increased the odds of getting at least 1 dose of hepatitis B, tetanus/diphtheria/acellular pertussis (Tdap), measles, and pneumococcal vaccine (OR = 1.75, 95% CI [1.063–2.864]; P = 0.028) CONCLUSION: In our cohort, kidney transplant recipients were more likely to have received pre-transplant vaccination. Despite the availability of local and international guidelines, vaccination in SOT candidates remains suboptimal and further study of barriers to implementation of these guidelines is warranted to inform future quality improvement initiatives. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809169/ http://dx.doi.org/10.1093/ofid/ofz360.1617 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Friedman, Daniel
Belga, Sara
Burton, Catherine
Preiksaitis, Jutta
Kabbani, Dima
1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title_full 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title_fullStr 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title_full_unstemmed 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title_short 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients
title_sort 1754. pre-transplant vaccination rates in solid-organ transplant recipients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809169/
http://dx.doi.org/10.1093/ofid/ofz360.1617
work_keys_str_mv AT friedmandaniel 1754pretransplantvaccinationratesinsolidorgantransplantrecipients
AT belgasara 1754pretransplantvaccinationratesinsolidorgantransplantrecipients
AT burtoncatherine 1754pretransplantvaccinationratesinsolidorgantransplantrecipients
AT preiksaitisjutta 1754pretransplantvaccinationratesinsolidorgantransplantrecipients
AT kabbanidima 1754pretransplantvaccinationratesinsolidorgantransplantrecipients